Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin

被引:42
作者
Chan-Tack, KM [1 ]
机构
[1] Univ Missouri, Dept Med, Columbia, MO USA
关键词
acute coronary syndromes; enoxaparin; hematoma;
D O I
10.1097/01.SMJ.0000047721.97440.02
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An 83-year-old woman was transferred to our cardiac intensive care unit with an acute non-Q-wave myocardial infarction and pulmonary edema. Enoxaparin was one component of the treatment regimen used. Her hospital course was complicated by episodes of hypotension, as well as by recurrent left hip and left thigh pain. The defining event occurred when the patient became acutely hypotensive and developed abdominal distention, peritoneal signs. intense left flank pain, and a 3.3 g/dl hemoglobin decrease. Abdominal computed tomography showed a 9 X 6 X 20 cm left retroperitoneal hematoma. The hematoma was spontaneous, secondary to enoxaparin use. The patient died despite vigorous supportive care, Enoxaparin is being increasingly used in patients with acute coronary syndromes. Review of the medical literature revealed that this is the first reported case of a patient with an acute coronary syndrome who died as a result of an enoxaparin-induced, spontaneous retroperitoneal hematoma. This article reviews important clinical signs and symptoms, identifies high-risk patient populations, and discusses management strategies.
引用
收藏
页码:58 / 60
页数:3
相关论文
共 10 条
  • [1] Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
    Antman, EM
    McCabe, CH
    Gurfinkel, EP
    Turpie, AGG
    Bernink, PJLM
    Salein, D
    de Luna, AB
    Fox, K
    Lablanche, JM
    Radley, D
    Premmereur, J
    Braunwald, E
    [J]. CIRCULATION, 1999, 100 (15) : 1593 - 1601
  • [2] Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis
    Antman, EM
    Cohen, M
    Radley, D
    McCabe, C
    Rush, J
    Premmereur, J
    Braunwald, E
    [J]. CIRCULATION, 1999, 100 (15) : 1602 - 1608
  • [3] Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474
  • [4] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
    Cohen, M
    Demers, C
    Gurfinkel, EP
    Turpie, AGG
    Fromell, GJ
    Goodman, S
    Langer, A
    Califf, RM
    Fox, KAA
    Premmereur, J
    Bigonzi, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) : 447 - 452
  • [5] Frydman A, 1996, HAEMOSTASIS, V26, P24
  • [6] LOW-MOLECULAR-WEIGHT HEPARIN VERSUS REGULAR HEPARIN OR ASPIRIN IN THE TREATMENT OF UNSTABLE ANGINA AND SILENT ISCHEMIA
    GURFINKEL, EP
    MANOS, EJ
    MEJAIL, RI
    CERDA, MA
    DURONTO, EA
    GARCIA, CN
    DAROCA, AM
    MAUTNER, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (02) : 313 - 318
  • [7] HIRSH J, 1992, BLOOD, V79, P1
  • [8] Retroperitoneal hematoma and enoxaparin
    Montoya, JP
    Pokala, N
    Melde, SL
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (10) : 796 - 797
  • [9] Enoxaparin - A review of its clinical potential in the management of coronary artery disease
    Noble, S
    Spencer, CM
    [J]. DRUGS, 1998, 56 (02) : 259 - 272
  • [10] Low-molecular-weight heparins
    Weitz, JI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) : 688 - 698